Category: Clinical Research

A recent 8-week double-blind, randomized, placebo-controlled trial investigated whether oral creatine monohydrate (5g/day) could enhance the effects of cognitive-behavioral therapy (CBT) in treating major depressive disorder (MDD)—especially in under-resourced areas where access to treatment is limited.

🔬 Why Does This Matter?
While CBT is a gold-standard therapy for depression, many patients do not achieve full remission. This study explored whether creatine—widely used for muscle and brain energy metabolism—could provide an extra boost to treatment.

🧠 Key Findings:
✅ Participants receiving creatine + CBT had greater reductions in depression symptoms (measured by the Hamilton Depression Rating Scale) compared to those receiving placebo + CBT
✅ Reported improvements in mood, energy levels, and cognitive function
✅ Creatine was well-tolerated, with no significant safety concerns
✅ CBT was delivered once weekly by trained therapists

⚠️ Study Limitations:
🔹 Small sample size—larger studies are needed to confirm these findings
🔹 Short trial duration—long-term effects are still unknown
🔹 Study population—results may not generalize to all individuals with MDD

💡 What’s Next?
If larger studies confirm these results, creatine could become an accessible, affordable adjunct to therapy, particularly in communities with limited mental health resources.

What do you think? Could a common fitness supplement help improve mental health? Let’s discuss! ⬇️

link to study: https://www.sciencedirect.com/science/article/pii/S0924977X24007405